The US healthcare system’s focus on activity rather than value for money was behind the demise of Proteus Digital Health and its “digital pill”, which measured whether schizophrenia patients took ...
Once valued at $1.5 billion, the Silicon Valley-based company founded in 2001 develops ingestible sensors that transmit when medicines are taken, plus a wearable patch reads the response. Proteus had ...
Integrated Structural Biology Department, IGBMC, UMR7104 CNRS, U1258 Inserm, University of Strasbourg, Illkirch 67404, France ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results